377 related articles for article (PubMed ID: 16399088)
1. Drugs for left ventricular remodeling in heart failure.
Frigerio M; Roubina E
Am J Cardiol; 2005 Dec; 96(12A):10L-18L. PubMed ID: 16399088
[TBL] [Abstract][Full Text] [Related]
2. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
Udelson JE; Konstam MA
J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
[TBL] [Abstract][Full Text] [Related]
3. The cellular and physiologic effects of beta blockers in heart failure.
Sabbah HN
Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
[TBL] [Abstract][Full Text] [Related]
4. Ventricular remodeling and its prevention in the treatment of heart failure.
Patten RD; Udelson JE; Konstam MA
Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
[TBL] [Abstract][Full Text] [Related]
5. Strategies to attenuate pathological remodeling in heart failure.
Eapen Z; Rogers JG
Curr Opin Cardiol; 2009 May; 24(3):223-9. PubMed ID: 19318933
[TBL] [Abstract][Full Text] [Related]
6. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
Khattar RS
Minerva Cardioangiol; 2003 Apr; 51(2):143-54. PubMed ID: 12783070
[TBL] [Abstract][Full Text] [Related]
7. Potential novel pharmacological therapies for myocardial remodelling.
Landmesser U; Wollert KC; Drexler H
Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic and clinical rationales for using beta-blockers in heart failure.
Bristow MR
J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
[TBL] [Abstract][Full Text] [Related]
9. Chronic heart failure: an overview of conventional treatment versus novel approaches.
Landmesser U; Drexler H
Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):628-38. PubMed ID: 16306919
[TBL] [Abstract][Full Text] [Related]
10. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
11. Heart failure: update on treatment and prognosis.
Futterman LG; Lemberg L
Am J Crit Care; 2001 Jul; 10(4):285-93. PubMed ID: 11432217
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
Greenberg BH
J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162
[TBL] [Abstract][Full Text] [Related]
13. New concepts in post-infarction ventricular remodeling.
Udelson JE; Patten RD; Konstam MA
Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L
J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852
[TBL] [Abstract][Full Text] [Related]
15. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic therapies across the continuum of left ventricular dysfunction.
Abraham WT; Greenberg BH; Yancy CW
Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
18. [Chronic heart failure treatment in the year 2006].
De Berrazueta Fernández JR
An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances and limitations of medical treatment on heart failure].
Momomura S
Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
[TBL] [Abstract][Full Text] [Related]
20. Ventricular remodeling in heart failure and the effect of beta-blockade.
Udelson JE
Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
